Arkolith/Insider Trading/OYST/Form 4

InvOpps GP IV, L.L.C.

Director, 10% OwnerOyster Point Pharma, Inc. (OYST) · full profile →Form 4 · filed Jan 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Tender(U)918K——0
Jan 3, 2023Tender(U)1.9M——0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-000999) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML